Nitazoxanide: A first-in-class broad-spectrum antiviral agent
Top Cited Papers
Open Access
- 7 August 2014
- journal article
- review article
- Published by Elsevier BV in Antiviral Research
- Vol. 110, 94-103
- https://doi.org/10.1016/j.antiviral.2014.07.014
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Systematic identification of synergistic drug pairs targeting HIVNature Biotechnology, 2012
- Norovirus gastroenteritis successfully treated with nitazoxanideJournal of Infection, 2011
- Mutations in HCV non-structural genes do not contribute to resistance to nitazoxanide in replicon-containing cellsAntiviral Research, 2011
- Nitazoxanide Disrupts Membrane Potential and Intrabacterial pH Homeostasis of Mycobacterium tuberculosisACS Medicinal Chemistry Letters, 2011
- The host interactome of influenza virus presents new potential targets for antiviral drugsReviews in Medical Virology, 2011
- Thiazolides as Novel Antiviral Agents. 1. Inhibition of Hepatitis B Virus ReplicationJournal of Medicinal Chemistry, 2011
- Thiazolides, a New Class of Anti-influenza Molecules Targeting Viral Hemagglutinin at the Post-translational LevelJournal of Biological Chemistry, 2009
- Study of the In Vitro Activities of Rifaximin and Comparator Agents against 536 Anaerobic Intestinal Bacteria from the Perspective of Potential Utility in Pathology Involving Bowel FloraAntimicrobial Agents and Chemotherapy, 2009
- Clinical Presentation ofMycoplasma genitaliumInfection versusNeisseria gonorrhoeaeInfection among Women with Pelvic Inflammatory DiseaseClinical Infectious Diseases, 2009
- Potential for Hepatitis C Virus Resistance to Nitazoxanide or TizoxanideAntimicrobial Agents and Chemotherapy, 2008